デフォルト表紙
市場調査レポート
商品コード
1124337

世界のワクチンアジュバント市場:考察と予測 (2028年まで)

Global Vaccine Adjuvants Market Insights and Forecast to 2028

出版日: | 発行: QYResearch | ページ情報: 英文 121 Pages | 納期: 2~3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報(例:国別セグメント)の追加などの対応が可能です。  詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=152.41円
世界のワクチンアジュバント市場:考察と予測 (2028年まで)
出版日: 2022年09月12日
発行: QYResearch
ページ情報: 英文 121 Pages
納期: 2~3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、ワクチンアジュバント (Vaccine Adjuvants) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 調査対象

  • ワクチンアジュバントの製品概要
  • 市場:タイプ別
    • 世界のワクチンアジュバントの市場規模成長率:タイプ別, 2017 VS 2021 VS 2028
    • Aluminum Adjuvant
    • Emulsions Adjuvant
    • Others
  • 市場:アプリケーション別
    • 世界のワクチンアジュバントの市場規模成長率:アプリケーション別, 2017 VS 2021 VS 2028
    • Human Vaccine
    • Veterinary Vaccine
  • 調査目的
  • 対象期間

第2章 レポート概要

  • 世界のワクチンアジュバントの販売 推定および予測 2017-2028
  • 世界のワクチンアジュバントの収益 推定および予測 2017-2028
  • 世界のワクチンアジュバントの収益:地域別: 2017 VS 2021 VS 2028
  • 世界のワクチンアジュバントの販売:地域別
    • 世界のワクチンアジュバントの販売:地域別 (2017-2022)
    • 世界の販売 ワクチンアジュバント :地域別 (2023-2028)
  • 世界のワクチンアジュバントの収益:地域別
    • 世界のワクチンアジュバントの収益:地域別 (2017-2022)
    • 世界のワクチンアジュバントの収益:地域別 (2023-2028)
  • 北米
  • 欧州
  • アジア太平洋地域
  • ラテンアメリカ
  • 中東・アフリカ

第3章 競合:メーカー別

  • 世界のワクチンアジュバントの販売:メーカー別
    • 世界のワクチンアジュバントの上位メーカー:販売別 (2017-2022)
    • 世界のワクチンアジュバントの販売市場シェア:メーカー別 (2017-2022)
    • 世界の上位10・上位5メーカー: ワクチンアジュバント2021
  • 世界のワクチンアジュバントの収益:メーカー別
    • 世界のワクチンアジュバントの収益:メーカー別 (2017-2022)
    • 世界のワクチンアジュバントの収益市場シェア:メーカー別 (2017-2022)
    • 世界の上位10・上位5企業: ワクチンアジュバントの収益 2021
  • 世界のワクチンアジュバントの販売価格:メーカー別 (2017-2022)
  • 競合情勢の分析
    • メーカーの市場集中度 (CR5 and HHI)
    • 世界のワクチンアジュバントの市場シェア:企業タイプ別 (Tier 1, Tier 2, and Tier 3)
    • 世界のワクチンアジュバントのメーカーの地理的分布
  • M&A, 拡張計画

第4章 市場規模:タイプ別

  • 世界のワクチンアジュバントの販売:タイプ別
    • 世界のワクチンアジュバントの販売実績:タイプ別 (2017-2022)
    • 世界のワクチンアジュバントの販売予測:タイプ別 (2023-2028)
    • 世界のワクチンアジュバントの販売市場シェア:タイプ別 (2017-2028)
  • 世界のワクチンアジュバントの収益:タイプ別
    • 世界のワクチンアジュバントの収益実績:タイプ別 (2017-2022)
    • 世界のワクチンアジュバントの収益予測:タイプ別 (2023-2028)
    • 世界のワクチンアジュバントの収益市場シェア:タイプ別 (2017-2028)
  • 世界のワクチンアジュバントの価格:タイプ別
    • 世界のワクチンアジュバントの価格:タイプ別 (2017-2022)
    • 世界のワクチンアジュバントの価格予測:タイプ別 (2023-2028)

第5章 市場規模:アプリケーション別

  • 世界のワクチンアジュバントの販売:アプリケーション別
    • 世界のワクチンアジュバントの販売実績:アプリケーション別 (2017-2022)
    • 世界のワクチンアジュバントの販売予測:アプリケーション別 (2023-2028)
    • 世界のワクチンアジュバントの販売市場シェア:アプリケーション別 (2017-2028)
  • 世界のワクチンアジュバントの収益:アプリケーション別
    • 世界のワクチンアジュバントの収益実績:アプリケーション別 (2017-2022)
    • 世界のワクチンアジュバントの収益予測:アプリケーション別 (2023-2028)
    • 世界のワクチンアジュバントの収益市場シェア:アプリケーション別 (2017-2028)
  • 世界のワクチンアジュバントの価格:アプリケーション別
    • 世界のワクチンアジュバントの価格:アプリケーション別 (2017-2022)
    • 世界のワクチンアジュバントの価格予測:アプリケーション別 (2023-2028)

第6章 北米

  • 北米のワクチンアジュバント 市場規模:タイプ別
    • 北米のワクチンアジュバントの販売:タイプ別 (2017-2028)
    • 北米のワクチンアジュバントの収益:タイプ別 (2017-2028)
  • 北米のワクチンアジュバント 市場規模:アプリケーション別
    • 北米のワクチンアジュバントの販売:アプリケーション別 (2017-2028)
    • 北米のワクチンアジュバントの収益:アプリケーション別 (2017-2028)
  • 北米のワクチンアジュバント 市場規模:国別
    • 北米のワクチンアジュバントの販売:国別 (2017-2028)
    • 北米のワクチンアジュバントの収益:国別 (2017-2028)
    • 米国
    • カナダ

第7章 欧州

  • 欧州のワクチンアジュバント 市場規模:タイプ別
    • 欧州のワクチンアジュバントの販売:タイプ別 (2017-2028)
    • 欧州のワクチンアジュバントの収益:タイプ別 (2017-2028)
  • 欧州のワクチンアジュバント 市場規模:アプリケーション別
    • 欧州のワクチンアジュバントの販売:アプリケーション別 (2017-2028)
    • 欧州のワクチンアジュバントの収益:アプリケーション別 (2017-2028)
  • 欧州のワクチンアジュバント 市場規模:国別
    • 欧州のワクチンアジュバントの販売:国別 (2017-2028)
    • 欧州のワクチンアジュバントの収益:国別 (2017-2028)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア

第8章 アジア太平洋

  • アジア太平洋のワクチンアジュバント 市場規模:タイプ別
    • アジア太平洋のワクチンアジュバントの販売:タイプ別 (2017-2028)
    • アジア太平洋のワクチンアジュバントの収益:タイプ別 (2017-2028)
  • アジア太平洋のワクチンアジュバント 市場規模:アプリケーション別
    • アジア太平洋のワクチンアジュバントの販売:アプリケーション別 (2017-2028)
    • アジア太平洋のワクチンアジュバントの収益:アプリケーション別 (2017-2028)
  • アジア太平洋のワクチンアジュバント 市場規模:地域別
    • アジア太平洋のワクチンアジュバントの販売:地域別 (2017-2028)
    • アジア太平洋のワクチンアジュバントの収益:地域別 (2017-2028)
    • 中国
    • 日本
    • 韓国
    • インド
    • オーストラリア
    • 台湾
    • インドネシア
    • タイ
    • マレーシア
    • フィリピン

第9章 ラテンアメリカ

  • ラテンアメリカのワクチンアジュバント 市場規模:タイプ別
    • ラテンアメリカのワクチンアジュバントの販売:タイプ別 (2017-2028)
    • ラテンアメリカのワクチンアジュバントの収益:タイプ別 (2017-2028)
  • ラテンアメリカのワクチンアジュバント 市場規模:アプリケーション別
    • ラテンアメリカのワクチンアジュバントの販売:アプリケーション別 (2017-2028)
    • ラテンアメリカのワクチンアジュバントの収益:アプリケーション別 (2017-2028)
  • ラテンアメリカのワクチンアジュバント 市場規模:国別
    • ラテンアメリカのワクチンアジュバントの販売:国別 (2017-2028)
    • ラテンアメリカのワクチンアジュバントの収益:国別 (2017-2028)
    • メキシコ
    • ブラジル
    • アルゼンチン

第10章 中東・アフリカ

  • 中東・アフリカのワクチンアジュバント 市場規模:タイプ別
    • 中東・アフリカのワクチンアジュバントの販売:タイプ別 (2017-2028)
    • 中東・アフリカのワクチンアジュバントの収益:タイプ別 (2017-2028)
  • 中東・アフリカのワクチンアジュバント 市場規模:アプリケーション別
    • 中東・アフリカのワクチンアジュバントの販売:アプリケーション別 (2017-2028)
    • 中東・アフリカのワクチンアジュバントの収益:アプリケーション別 (2017-2028)
  • 中東・アフリカのワクチンアジュバント 市場規模:国別
    • 中東・アフリカのワクチンアジュバントの販売:国別 (2017-2028)
    • 中東・アフリカのワクチンアジュバントの収益:国別 (2017-2028)
    • トルコ
    • サウジアラビア

第11章 企業プロファイル

  • GSK
  • CSL Limited
  • Croda
  • SEPPIC
  • Novavax
  • SPI Pharma
  • Phibro
  • SDA BIO
  • Invivogen
  • Tj Kaiwei
  • OZ Biosciences
  • Brenntag Biosector
  • MVP Laboratories
  • Zhuoyue
  • Aphios

第12章 業界チェーンと販売チャネルの分析

  • ワクチンアジュバント 業界チェーン分析
  • ワクチンアジュバント 主要原材料分析
    • 主要原材料分析
    • 原材料の主要サプライヤー
  • ワクチンアジュバント 生産形態とプロセス
  • ワクチンアジュバント 販売およびマーケティング
    • ワクチンアジュバント 販売チャネル
    • ワクチンアジュバント 卸業者
  • ワクチンアジュバント 顧客

第13章 市場の促進要因, 機会, 課題とリスク要因の分析

  • ワクチンアジュバント 業界動向
  • ワクチンアジュバント 市場の促進要因
  • ワクチンアジュバント 市場の課題
  • ワクチンアジュバント 市場の抑制要因

第14章 世界のワクチンアジュバントの主な市場調査結果

第15章 付録

図表
  • Table 1. Global Vaccine Adjuvants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 2. Major Manufacturers of Aluminum Adjuvant
  • Table 3. Major Manufacturers of Emulsions Adjuvant
  • Table 4. Major Manufacturers of Others
  • Table 5. Global Vaccine Adjuvants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
  • Table 6. Global Vaccine Adjuvants Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
  • Table 7. Global Vaccine Adjuvants Sales by Region (2017-2022) & (MT)
  • Table 8. Global Vaccine Adjuvants Sales Market Share by Region (2017-2022)
  • Table 9. Global Vaccine Adjuvants Sales by Region (2023-2028) & (MT)
  • Table 10. Global Vaccine Adjuvants Sales Market Share by Region (2023-2028)
  • Table 11. Global Vaccine Adjuvants Revenue by Region (2017-2022) & (US$ Million)
  • Table 12. Global Vaccine Adjuvants Revenue Market Share by Region (2017-2022)
  • Table 13. Global Vaccine Adjuvants Revenue by Region (2023-2028) & (US$ Million)
  • Table 14. Global Vaccine Adjuvants Revenue Market Share by Region (2023-2028)
  • Table 15. Global Vaccine Adjuvants Sales by Manufacturers (2017-2022) & (MT)
  • Table 16. Global Vaccine Adjuvants Sales Share by Manufacturers (2017-2022)
  • Table 17. Global Vaccine Adjuvants Revenue by Manufacturers (2017-2022) & (US$ Million)
  • Table 18. Global Vaccine Adjuvants Revenue Share by Manufacturers (2017-2022)
  • Table 19. Vaccine Adjuvants Price by Manufacturers (2017-2022) &(USD/Kg)
  • Table 20. Global Vaccine Adjuvants Manufacturers Market Concentration Ratio (CR5 and HHI)
  • Table 21. Global Vaccine Adjuvants by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Vaccine Adjuvants as of 2021)
  • Table 22. Vaccine Adjuvants Manufacturing Base Distribution and Headquarters
  • Table 23. Manufacturers Vaccine Adjuvants Product Offered
  • Table 24. Date of Manufacturers Enter into Vaccine Adjuvants Market
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
  • Table 27. Global Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
  • Table 28. Global Vaccine Adjuvants Sales Share by Type (2017-2022)
  • Table 29. Global Vaccine Adjuvants Sales Share by Type (2023-2028)
  • Table 30. Global Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
  • Table 31. Global Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
  • Table 32. Global Vaccine Adjuvants Revenue Share by Type (2017-2022)
  • Table 33. Global Vaccine Adjuvants Revenue Share by Type (2023-2028)
  • Table 34. Vaccine Adjuvants Price by Type (2017-2022) & (USD/Kg)
  • Table 35. Global Vaccine Adjuvants Price Forecast by Type (2023-2028) & (USD/Kg)
  • Table 36. Global Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
  • Table 37. Global Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
  • Table 38. Global Vaccine Adjuvants Sales Share by Application (2017-2022)
  • Table 39. Global Vaccine Adjuvants Sales Share by Application (2023-2028)
  • Table 40. Global Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
  • Table 41. Global Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
  • Table 42. Global Vaccine Adjuvants Revenue Share by Application (2017-2022)
  • Table 43. Global Vaccine Adjuvants Revenue Share by Application (2023-2028)
  • Table 44. Vaccine Adjuvants Price by Application (2017-2022) & (USD/Kg)
  • Table 45. Global Vaccine Adjuvants Price Forecast by Application (2023-2028) & (USD/Kg)
  • Table 46. North America Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
  • Table 47. North America Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
  • Table 48. North America Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
  • Table 49. North America Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
  • Table 50. North America Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
  • Table 51. North America Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
  • Table 52. North America Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
  • Table 53. North America Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
  • Table 54. North America Vaccine Adjuvants Sales by Country (2017-2022) & (MT)
  • Table 55. North America Vaccine Adjuvants Sales by Country (2023-2028) & (MT)
  • Table 56. North America Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
  • Table 57. North America Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
  • Table 58. Europe Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
  • Table 59. Europe Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
  • Table 60. Europe Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
  • Table 61. Europe Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
  • Table 62. Europe Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
  • Table 63. Europe Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
  • Table 64. Europe Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
  • Table 65. Europe Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
  • Table 66. Europe Vaccine Adjuvants Sales by Country (2017-2022) & (MT)
  • Table 67. Europe Vaccine Adjuvants Sales by Country (2023-2028) & (MT)
  • Table 68. Europe Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
  • Table 69. Europe Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
  • Table 70. Asia Pacific Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
  • Table 71. Asia Pacific Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
  • Table 72. Asia Pacific Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
  • Table 73. Asia Pacific Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
  • Table 74. Asia Pacific Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
  • Table 75. Asia Pacific Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
  • Table 76. Asia Pacific Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
  • Table 77. Asia Pacific Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
  • Table 78. Asia Pacific Vaccine Adjuvants Sales by Region (2017-2022) & (MT)
  • Table 79. Asia Pacific Vaccine Adjuvants Sales by Region (2023-2028) & (MT)
  • Table 80. Asia Pacific Vaccine Adjuvants Revenue by Region (2017-2022) & (US$ Million)
  • Table 81. Asia Pacific Vaccine Adjuvants Revenue by Region (2023-2028) & (US$ Million)
  • Table 82. Latin America Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
  • Table 83. Latin America Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
  • Table 84. Latin America Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
  • Table 85. Latin America Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
  • Table 86. Latin America Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
  • Table 87. Latin America Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
  • Table 88. Latin America Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
  • Table 89. Latin America Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
  • Table 90. Latin America Vaccine Adjuvants Sales by Country (2017-2022) & (MT)
  • Table 91. Latin America Vaccine Adjuvants Sales by Country (2023-2028) & (MT)
  • Table 92. Latin America Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
  • Table 93. Latin America Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
  • Table 94. Middle East and Africa Vaccine Adjuvants Sales by Type (2017-2022) & (MT)
  • Table 95. Middle East and Africa Vaccine Adjuvants Sales by Type (2023-2028) & (MT)
  • Table 96. Middle East and Africa Vaccine Adjuvants Revenue by Type (2017-2022) & (US$ Million)
  • Table 97. Middle East and Africa Vaccine Adjuvants Revenue by Type (2023-2028) & (US$ Million)
  • Table 98. Middle East and Africa Vaccine Adjuvants Sales by Application (2017-2022) & (MT)
  • Table 99. Middle East and Africa Vaccine Adjuvants Sales by Application (2023-2028) & (MT)
  • Table 100. Middle East and Africa Vaccine Adjuvants Revenue by Application (2017-2022) & (US$ Million)
  • Table 101. Middle East and Africa Vaccine Adjuvants Revenue by Application (2023-2028) & (US$ Million)
  • Table 102. Middle East and Africa Vaccine Adjuvants Sales by Country (2017-2022) & (MT)
  • Table 103. Middle East and Africa Vaccine Adjuvants Sales by Country (2023-2028) & (MT)
  • Table 104. Middle East and Africa Vaccine Adjuvants Revenue by Country (2017-2022) & (US$ Million)
  • Table 105. Middle East and Africa Vaccine Adjuvants Revenue by Country (2023-2028) & (US$ Million)
  • Table 106. GSK Corporation Information
  • Table 107. GSK Description and Major Businesses
  • Table 108. GSK Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
  • Table 109. GSK Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 110. GSK Recent Developments
  • Table 111. CSL Limited Corporation Information
  • Table 112. CSL Limited Description and Major Businesses
  • Table 113. CSL Limited Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
  • Table 114. CSL Limited Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 115. CSL Limited Recent Developments
  • Table 116. Croda Corporation Information
  • Table 117. Croda Description and Major Businesses
  • Table 118. Croda Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
  • Table 119. Croda Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 120. Croda Recent Developments
  • Table 121. SEPPIC Corporation Information
  • Table 122. SEPPIC Description and Major Businesses
  • Table 123. SEPPIC Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
  • Table 124. SEPPIC Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 125. SEPPIC Recent Developments
  • Table 126. Novavax Corporation Information
  • Table 127. Novavax Description and Major Businesses
  • Table 128. Novavax Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
  • Table 129. Novavax Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 130. Novavax Recent Developments
  • Table 131. SPI Pharma Corporation Information
  • Table 132. SPI Pharma Description and Major Businesses
  • Table 133. SPI Pharma Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
  • Table 134. SPI Pharma Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 135. SPI Pharma Recent Developments
  • Table 136. Phibro Corporation Information
  • Table 137. Phibro Description and Major Businesses
  • Table 138. Phibro Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
  • Table 139. Phibro Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 140. Phibro Recent Developments
  • Table 141. SDA BIO Corporation Information
  • Table 142. SDA BIO Description and Major Businesses
  • Table 143. SDA BIO Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
  • Table 144. SDA BIO Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 145. SDA BIO Recent Developments
  • Table 146. Invivogen Corporation Information
  • Table 147. Invivogen Description and Major Businesses
  • Table 148. Invivogen Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
  • Table 149. Invivogen Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 150. Invivogen Recent Developments
  • Table 151. Tj Kaiwei Corporation Information
  • Table 152. Tj Kaiwei Description and Major Businesses
  • Table 153. Tj Kaiwei Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
  • Table 154. Tj Kaiwei Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 155. Tj Kaiwei Recent Developments
  • Table 156. OZ Biosciences Corporation Information
  • Table 157. OZ Biosciences Description and Major Businesses
  • Table 158. OZ Biosciences Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
  • Table 159. OZ Biosciences Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 160. OZ Biosciences Recent Developments
  • Table 161. Brenntag Biosector Corporation Information
  • Table 162. Brenntag Biosector Description and Major Businesses
  • Table 163. Brenntag Biosector Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
  • Table 164. Brenntag Biosector Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 165. Brenntag Biosector Recent Developments
  • Table 166. MVP Laboratories Corporation Information
  • Table 167. MVP Laboratories Description and Major Businesses
  • Table 168. MVP Laboratories Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
  • Table 169. MVP Laboratories Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 170. MVP Laboratories Recent Developments
  • Table 171. Zhuoyue Corporation Information
  • Table 172. Zhuoyue Description and Major Businesses
  • Table 173. Zhuoyue Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
  • Table 174. Zhuoyue Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 175. Zhuoyue Recent Developments
  • Table 176. Aphios Corporation Information
  • Table 177. Aphios Description and Major Businesses
  • Table 178. Aphios Vaccine Adjuvants Sales (MT), Revenue (US$ Million), Price (USD/Kg) and Gross Margin (2017-2022)
  • Table 179. Aphios Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
  • Table 180. Aphios Recent Developments
  • Table 181. Key Raw Materials Lists
  • Table 182. Raw Materials Key Suppliers Lists
  • Table 183. Vaccine Adjuvants Distributors List
  • Table 184. Vaccine Adjuvants Customers List
  • Table 185. Vaccine Adjuvants Market Trends
  • Table 186. Vaccine Adjuvants Market Drivers
  • Table 187. Vaccine Adjuvants Market Challenges
  • Table 188. Vaccine Adjuvants Market Restraints
  • Table 189. Research Programs/Design for This Report
  • Table 190. Key Data Information from Secondary Sources
  • Table 191. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Vaccine Adjuvants Product Picture
  • Figure 3. Global Vaccine Adjuvants Market Share by Type in 2021 & 2028
  • Figure 3. Aluminum Adjuvant Product Picture
  • Figure 4. Emulsions Adjuvant Product Picture
  • Figure 5. Others Product Picture
  • Figure 6. Global Vaccine Adjuvants Market Share by Application in 2021 & 2028
  • Figure 7. Human Vaccine
  • Figure 8. Veterinary Vaccine
  • Figure 9. Vaccine Adjuvants Report Years Considered
  • Figure 10. Global Vaccine Adjuvants Sales 2017-2028 (MT)
  • Figure 11. Global Vaccine Adjuvants Revenue, (US$ Million), 2017 VS 2021 VS 2028
  • Figure 12. Global Vaccine Adjuvants Revenue 2017-2028 (US$ Million)
  • Figure 13. Global Vaccine Adjuvants Revenue Market Share by Region in Percentage: 2021 Versus 2028
  • Figure 14. Global Vaccine Adjuvants Sales Market Share by Region (2017-2022)
  • Figure 15. Global Vaccine Adjuvants Sales Market Share by Region (2023-2028)
  • Figure 16. North America Vaccine Adjuvants Sales YoY (2017-2028) & (MT)
  • Figure 17. North America Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
  • Figure 18. Europe Vaccine Adjuvants Sales YoY (2017-2028) & (MT)
  • Figure 19. Europe Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
  • Figure 20. Asia-Pacific Vaccine Adjuvants Sales YoY (2017-2028) & (MT)
  • Figure 21. Asia-Pacific Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
  • Figure 22. Latin America Vaccine Adjuvants Sales YoY (2017-2028) & (MT)
  • Figure 23. Latin America Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
  • Figure 24. Middle East & Africa Vaccine Adjuvants Sales YoY (2017-2028) & (MT)
  • Figure 25. Middle East & Africa Vaccine Adjuvants Revenue YoY (2017-2028) & (US$ Million)
  • Figure 26. The Vaccine Adjuvants Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
  • Figure 27. The Top 5 and 10 Largest Manufacturers of Vaccine Adjuvants in the World: Market Share by Vaccine Adjuvants Revenue in 2021
  • Figure 28. Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
  • Figure 29. Global Vaccine Adjuvants Sales Market Share by Type (2017-2028)
  • Figure 30. Global Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
  • Figure 31. Global Vaccine Adjuvants Sales Market Share by Application (2017-2028)
  • Figure 32. Global Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
  • Figure 33. North America Vaccine Adjuvants Sales Market Share by Type (2017-2028)
  • Figure 34. North America Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
  • Figure 35. North America Vaccine Adjuvants Sales Market Share by Application (2017-2028)
  • Figure 36. North America Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
  • Figure 37. North America Vaccine Adjuvants Sales Share by Country (2017-2028)
  • Figure 38. North America Vaccine Adjuvants Revenue Share by Country (2017-2028)
  • Figure 39. U.S. Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 40. Canada Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 41. Europe Vaccine Adjuvants Sales Market Share by Type (2017-2028)
  • Figure 42. Europe Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
  • Figure 43. Europe Vaccine Adjuvants Sales Market Share by Application (2017-2028)
  • Figure 44. Europe Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
  • Figure 45. Europe Vaccine Adjuvants Sales Share by Country (2017-2028)
  • Figure 46. Europe Vaccine Adjuvants Revenue Share by Country (2017-2028)
  • Figure 47. Germany Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 48. France Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 49. U.K. Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 50. Italy Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 51. Russia Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 52. Asia Pacific Vaccine Adjuvants Sales Market Share by Type (2017-2028)
  • Figure 53. Asia Pacific Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
  • Figure 54. Asia Pacific Vaccine Adjuvants Sales Market Share by Application (2017-2028)
  • Figure 55. Asia Pacific Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
  • Figure 56. Asia Pacific Vaccine Adjuvants Sales Share by Region (2017-2028)
  • Figure 57. Asia Pacific Vaccine Adjuvants Revenue Share by Region (2017-2028)
  • Figure 58. China Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 59. Japan Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 60. South Korea Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 61. India Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 62. Australia Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 63. Taiwan Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 64. Indonesia Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 65. Thailand Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 66. Malaysia Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 67. Philippines Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 68. Latin America Vaccine Adjuvants Sales Market Share by Type (2017-2028)
  • Figure 69. Latin America Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
  • Figure 70. Latin America Vaccine Adjuvants Sales Market Share by Application (2017-2028)
  • Figure 71. Latin America Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
  • Figure 72. Latin America Vaccine Adjuvants Sales Share by Country (2017-2028)
  • Figure 73. Latin America Vaccine Adjuvants Revenue Share by Country (2017-2028)
  • Figure 74. Mexico Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 75. Brazil Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 76. Argentina Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 77. Middle East and Africa Vaccine Adjuvants Sales Market Share by Type (2017-2028)
  • Figure 78. Middle East and Africa Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
  • Figure 79. Middle East and Africa Vaccine Adjuvants Sales Market Share by Application (2017-2028)
  • Figure 80. Middle East and Africa Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
  • Figure 81. Middle East and Africa Vaccine Adjuvants Sales Share by Country (2017-2028)
  • Figure 82. Middle East and Africa Vaccine Adjuvants Revenue Share by Country (2017-2028)
  • Figure 83. Turkey Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 84. Saudi Arabia Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 85. U.A.E Vaccine Adjuvants Revenue (2017-2028) & (US$ Million)
  • Figure 86. Vaccine Adjuvants Value Chain
  • Figure 87. Vaccine Adjuvants Production Process
  • Figure 88. Channels of Distribution
  • Figure 89. Distributors Profiles
  • Figure 90. Bottom-up and Top-down Approaches for This Report
  • Figure 91. Data Triangulation
  • Figure 92. Key Executives Interviewed
目次

This research report focuses on the Vaccine Adjuvants Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Study Coverage

  • 1.1 Vaccine Adjuvants Product Introduction
  • 1.2 Market by Type
    • 1.2.1 Global Vaccine Adjuvants Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
    • 1.2.2 Aluminum Adjuvant
    • 1.2.3 Emulsions Adjuvant
    • 1.2.4 Others
  • 1.3 Market by Application
    • 1.3.1 Global Vaccine Adjuvants Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
    • 1.3.2 Human Vaccine
    • 1.3.3 Veterinary Vaccine
  • 1.4 Study Objectives
  • 1.5 Years Considered

2 Executive Summary

  • 2.1 Global Vaccine Adjuvants Sales Estimates and Forecasts 2017-2028
  • 2.2 Global Vaccine Adjuvants Revenue Estimates and Forecasts 2017-2028
  • 2.3 Global Vaccine Adjuvants Revenue by Region: 2017 VS 2021 VS 2028
  • 2.4 Global Vaccine Adjuvants Sales by Region
    • 2.4.1 Global Vaccine Adjuvants Sales by Region (2017-2022)
    • 2.4.2 Global Sales Vaccine Adjuvants by Region (2023-2028)
  • 2.5 Global Vaccine Adjuvants Revenue by Region
    • 2.5.1 Global Vaccine Adjuvants Revenue by Region (2017-2022)
    • 2.5.2 Global Vaccine Adjuvants Revenue by Region (2023-2028)
  • 2.6 North America
  • 2.7 Europe
  • 2.8 Asia-Pacific
  • 2.9 Latin America
  • 2.10 Middle East & Africa

3 Competition by Manufacturers

  • 3.1 Global Vaccine Adjuvants Sales by Manufacturers
    • 3.1.1 Global Top Vaccine Adjuvants Manufacturers by Sales (2017-2022)
    • 3.1.2 Global Vaccine Adjuvants Sales Market Share by Manufacturers (2017-2022)
    • 3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Vaccine Adjuvants in 2021
  • 3.2 Global Vaccine Adjuvants Revenue by Manufacturers
    • 3.2.1 Global Vaccine Adjuvants Revenue by Manufacturers (2017-2022)
    • 3.2.2 Global Vaccine Adjuvants Revenue Market Share by Manufacturers (2017-2022)
    • 3.2.3 Global Top 10 and Top 5 Companies by Vaccine Adjuvants Revenue in 2021
  • 3.3 Global Vaccine Adjuvants Sales Price by Manufacturers (2017-2022)
  • 3.4 Analysis of Competitive Landscape
    • 3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Vaccine Adjuvants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    • 3.4.3 Global Vaccine Adjuvants Manufacturers Geographical Distribution
  • 3.5 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type

  • 4.1 Global Vaccine Adjuvants Sales by Type
    • 4.1.1 Global Vaccine Adjuvants Historical Sales by Type (2017-2022)
    • 4.1.2 Global Vaccine Adjuvants Forecasted Sales by Type (2023-2028)
    • 4.1.3 Global Vaccine Adjuvants Sales Market Share by Type (2017-2028)
  • 4.2 Global Vaccine Adjuvants Revenue by Type
    • 4.2.1 Global Vaccine Adjuvants Historical Revenue by Type (2017-2022)
    • 4.2.2 Global Vaccine Adjuvants Forecasted Revenue by Type (2023-2028)
    • 4.2.3 Global Vaccine Adjuvants Revenue Market Share by Type (2017-2028)
  • 4.3 Global Vaccine Adjuvants Price by Type
    • 4.3.1 Global Vaccine Adjuvants Price by Type (2017-2022)
    • 4.3.2 Global Vaccine Adjuvants Price Forecast by Type (2023-2028)

5 Market Size by Application

  • 5.1 Global Vaccine Adjuvants Sales by Application
    • 5.1.1 Global Vaccine Adjuvants Historical Sales by Application (2017-2022)
    • 5.1.2 Global Vaccine Adjuvants Forecasted Sales by Application (2023-2028)
    • 5.1.3 Global Vaccine Adjuvants Sales Market Share by Application (2017-2028)
  • 5.2 Global Vaccine Adjuvants Revenue by Application
    • 5.2.1 Global Vaccine Adjuvants Historical Revenue by Application (2017-2022)
    • 5.2.2 Global Vaccine Adjuvants Forecasted Revenue by Application (2023-2028)
    • 5.2.3 Global Vaccine Adjuvants Revenue Market Share by Application (2017-2028)
  • 5.3 Global Vaccine Adjuvants Price by Application
    • 5.3.1 Global Vaccine Adjuvants Price by Application (2017-2022)
    • 5.3.2 Global Vaccine Adjuvants Price Forecast by Application (2023-2028)

6 North America

  • 6.1 North America Vaccine Adjuvants Market Size by Type
    • 6.1.1 North America Vaccine Adjuvants Sales by Type (2017-2028)
    • 6.1.2 North America Vaccine Adjuvants Revenue by Type (2017-2028)
  • 6.2 North America Vaccine Adjuvants Market Size by Application
    • 6.2.1 North America Vaccine Adjuvants Sales by Application (2017-2028)
    • 6.2.2 North America Vaccine Adjuvants Revenue by Application (2017-2028)
  • 6.3 North America Vaccine Adjuvants Market Size by Country
    • 6.3.1 North America Vaccine Adjuvants Sales by Country (2017-2028)
    • 6.3.2 North America Vaccine Adjuvants Revenue by Country (2017-2028)
    • 6.3.3 U.S.
    • 6.3.4 Canada

7 Europe

  • 7.1 Europe Vaccine Adjuvants Market Size by Type
    • 7.1.1 Europe Vaccine Adjuvants Sales by Type (2017-2028)
    • 7.1.2 Europe Vaccine Adjuvants Revenue by Type (2017-2028)
  • 7.2 Europe Vaccine Adjuvants Market Size by Application
    • 7.2.1 Europe Vaccine Adjuvants Sales by Application (2017-2028)
    • 7.2.2 Europe Vaccine Adjuvants Revenue by Application (2017-2028)
  • 7.3 Europe Vaccine Adjuvants Market Size by Country
    • 7.3.1 Europe Vaccine Adjuvants Sales by Country (2017-2028)
    • 7.3.2 Europe Vaccine Adjuvants Revenue by Country (2017-2028)
    • 7.3.3 Germany
    • 7.3.4 France
    • 7.3.5 U.K.
    • 7.3.6 Italy
    • 7.3.7 Russia

8 Asia Pacific

  • 8.1 Asia Pacific Vaccine Adjuvants Market Size by Type
    • 8.1.1 Asia Pacific Vaccine Adjuvants Sales by Type (2017-2028)
    • 8.1.2 Asia Pacific Vaccine Adjuvants Revenue by Type (2017-2028)
  • 8.2 Asia Pacific Vaccine Adjuvants Market Size by Application
    • 8.2.1 Asia Pacific Vaccine Adjuvants Sales by Application (2017-2028)
    • 8.2.2 Asia Pacific Vaccine Adjuvants Revenue by Application (2017-2028)
  • 8.3 Asia Pacific Vaccine Adjuvants Market Size by Region
    • 8.3.1 Asia Pacific Vaccine Adjuvants Sales by Region (2017-2028)
    • 8.3.2 Asia Pacific Vaccine Adjuvants Revenue by Region (2017-2028)
    • 8.3.3 China
    • 8.3.4 Japan
    • 8.3.5 South Korea
    • 8.3.6 India
    • 8.3.7 Australia
    • 8.3.8 Taiwan
    • 8.3.9 Indonesia
    • 8.3.10 Thailand
    • 8.3.11 Malaysia
    • 8.3.12 Philippines

9 Latin America

  • 9.1 Latin America Vaccine Adjuvants Market Size by Type
    • 9.1.1 Latin America Vaccine Adjuvants Sales by Type (2017-2028)
    • 9.1.2 Latin America Vaccine Adjuvants Revenue by Type (2017-2028)
  • 9.2 Latin America Vaccine Adjuvants Market Size by Application
    • 9.2.1 Latin America Vaccine Adjuvants Sales by Application (2017-2028)
    • 9.2.2 Latin America Vaccine Adjuvants Revenue by Application (2017-2028)
  • 9.3 Latin America Vaccine Adjuvants Market Size by Country
    • 9.3.1 Latin America Vaccine Adjuvants Sales by Country (2017-2028)
    • 9.3.2 Latin America Vaccine Adjuvants Revenue by Country (2017-2028)
    • 9.3.3 Mexico
    • 9.3.4 Brazil
    • 9.3.5 Argentina

10 Middle East and Africa

  • 10.1 Middle East and Africa Vaccine Adjuvants Market Size by Type
    • 10.1.1 Middle East and Africa Vaccine Adjuvants Sales by Type (2017-2028)
    • 10.1.2 Middle East and Africa Vaccine Adjuvants Revenue by Type (2017-2028)
  • 10.2 Middle East and Africa Vaccine Adjuvants Market Size by Application
    • 10.2.1 Middle East and Africa Vaccine Adjuvants Sales by Application (2017-2028)
    • 10.2.2 Middle East and Africa Vaccine Adjuvants Revenue by Application (2017-2028)
  • 10.3 Middle East and Africa Vaccine Adjuvants Market Size by Country
    • 10.3.1 Middle East and Africa Vaccine Adjuvants Sales by Country (2017-2028)
    • 10.3.2 Middle East and Africa Vaccine Adjuvants Revenue by Country (2017-2028)
    • 10.3.3 Turkey
    • 10.3.4 Saudi Arabia

11 Company Profiles

  • 11.1 GSK
    • 11.1.1 GSK Corporation Information
    • 11.1.2 GSK Overview
    • 11.1.3 GSK Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.1.4 GSK Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.1.5 GSK Recent Developments
  • 11.2 CSL Limited
    • 11.2.1 CSL Limited Corporation Information
    • 11.2.2 CSL Limited Overview
    • 11.2.3 CSL Limited Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.2.4 CSL Limited Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.2.5 CSL Limited Recent Developments
  • 11.3 Croda
    • 11.3.1 Croda Corporation Information
    • 11.3.2 Croda Overview
    • 11.3.3 Croda Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.3.4 Croda Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.3.5 Croda Recent Developments
  • 11.4 SEPPIC
    • 11.4.1 SEPPIC Corporation Information
    • 11.4.2 SEPPIC Overview
    • 11.4.3 SEPPIC Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.4.4 SEPPIC Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.4.5 SEPPIC Recent Developments
  • 11.5 Novavax
    • 11.5.1 Novavax Corporation Information
    • 11.5.2 Novavax Overview
    • 11.5.3 Novavax Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.5.4 Novavax Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.5.5 Novavax Recent Developments
  • 11.6 SPI Pharma
    • 11.6.1 SPI Pharma Corporation Information
    • 11.6.2 SPI Pharma Overview
    • 11.6.3 SPI Pharma Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.6.4 SPI Pharma Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.6.5 SPI Pharma Recent Developments
  • 11.7 Phibro
    • 11.7.1 Phibro Corporation Information
    • 11.7.2 Phibro Overview
    • 11.7.3 Phibro Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.7.4 Phibro Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.7.5 Phibro Recent Developments
  • 11.8 SDA BIO
    • 11.8.1 SDA BIO Corporation Information
    • 11.8.2 SDA BIO Overview
    • 11.8.3 SDA BIO Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.8.4 SDA BIO Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.8.5 SDA BIO Recent Developments
  • 11.9 Invivogen
    • 11.9.1 Invivogen Corporation Information
    • 11.9.2 Invivogen Overview
    • 11.9.3 Invivogen Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.9.4 Invivogen Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.9.5 Invivogen Recent Developments
  • 11.10 Tj Kaiwei
    • 11.10.1 Tj Kaiwei Corporation Information
    • 11.10.2 Tj Kaiwei Overview
    • 11.10.3 Tj Kaiwei Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.10.4 Tj Kaiwei Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.10.5 Tj Kaiwei Recent Developments
  • 11.11 OZ Biosciences
    • 11.11.1 OZ Biosciences Corporation Information
    • 11.11.2 OZ Biosciences Overview
    • 11.11.3 OZ Biosciences Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.11.4 OZ Biosciences Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.11.5 OZ Biosciences Recent Developments
  • 11.12 Brenntag Biosector
    • 11.12.1 Brenntag Biosector Corporation Information
    • 11.12.2 Brenntag Biosector Overview
    • 11.12.3 Brenntag Biosector Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.12.4 Brenntag Biosector Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.12.5 Brenntag Biosector Recent Developments
  • 11.13 MVP Laboratories
    • 11.13.1 MVP Laboratories Corporation Information
    • 11.13.2 MVP Laboratories Overview
    • 11.13.3 MVP Laboratories Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.13.4 MVP Laboratories Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.13.5 MVP Laboratories Recent Developments
  • 11.14 Zhuoyue
    • 11.14.1 Zhuoyue Corporation Information
    • 11.14.2 Zhuoyue Overview
    • 11.14.3 Zhuoyue Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.14.4 Zhuoyue Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.14.5 Zhuoyue Recent Developments
  • 11.15 Aphios
    • 11.15.1 Aphios Corporation Information
    • 11.15.2 Aphios Overview
    • 11.15.3 Aphios Vaccine Adjuvants Sales, Price, Revenue and Gross Margin (2017-2022)
    • 11.15.4 Aphios Vaccine Adjuvants Product Model Numbers, Pictures, Descriptions and Specifications
    • 11.15.5 Aphios Recent Developments

12 Industry Chain and Sales Channels Analysis

  • 12.1 Vaccine Adjuvants Industry Chain Analysis
  • 12.2 Vaccine Adjuvants Key Raw Materials
    • 12.2.1 Key Raw Materials
    • 12.2.2 Raw Materials Key Suppliers
  • 12.3 Vaccine Adjuvants Production Mode & Process
  • 12.4 Vaccine Adjuvants Sales and Marketing
    • 12.4.1 Vaccine Adjuvants Sales Channels
    • 12.4.2 Vaccine Adjuvants Distributors
  • 12.5 Vaccine Adjuvants Customers

13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis

  • 13.1 Vaccine Adjuvants Industry Trends
  • 13.2 Vaccine Adjuvants Market Drivers
  • 13.3 Vaccine Adjuvants Market Challenges
  • 13.4 Vaccine Adjuvants Market Restraints

14 Key Findings in The Global Vaccine Adjuvants Study

15 Appendix

  • 15.1 Research Methodology
    • 15.1.1 Methodology/Research Approach
    • 15.1.2 Data Source
  • 15.2 Author Details
  • 15.3 Disclaimer